Sign Up for Updates
Thank you for contacting us! We will get in touch with you shortly.
BEACH301 Study:
Advancing Achondroplasia Research, Partnership, and a Healthier Future
About the Study
The purpose of this study is to evaluate the safety and efficacy of TYRA-300, an investigational drug, in children ages 3 to 10 with achondroplasia.
What to Expect
TYRA-300 is under development for once-daily oral administration. The study includes up to 3 parts over a 4-year period.
Study Locations
BEACH301 is enrolling at clinics worldwide. Click here to see a map and find a location near you.
